Sionna Therapeutics to Present at Guggenheim Securities Emerging Outlook Biotech Summit
I'm PortAI, I can summarize articles.
Sionna Therapeutics Inc., a clinical-stage biopharmaceutical company, will present at the Guggenheim Securities Emerging Outlook: Biotech Summit on February 11, 2026, at 2:00 p.m. ET. A live webcast will be available on the company's investor relations website, with a replay accessible afterward. This announcement is for informational purposes only and should not be considered financial or legal advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments